|

TRIPP Wants You to ‘Be Here Now,’ With or Without Ram Dass

TRIPP Wants You to 'Be Here Now,' With or Without Ram Dass
TRIPP Wants You to 'Be Here Now,' With or Without Ram Dass

TRIPP CEO and Co-Founder Nanea Reeves wants everyone who uses the virtual and augmented reality platform to learn how to be here now.

And they can even practice with renowned spiritual teacher Ram Dass himself, the man who famously coined that phrase with the 1971 publication of his iconic book Be Here Now, which Reeves and her team helped celebrate the weekend before Halloween at Wisdome LA.

TRIPP partnered with the Love Serve Remember Foundation to premiere a VR experience called JOURNEY, inspired by Ram Dass’ first psilocybin trip and his teachings, during the 50th-anniversary celebration of the beloved book. The short film utilized his voice from old lectures as well as personal photographs and trippy imagery to immerse hundreds of his admirers in 360-degree virtual reality.

I watched with delight as we toured Ram Dass’ virtual living room, with his voice booming through the dome sharing his life-changing dance through the mind, when he first experienced ego death and got a glimpse of the Divine — an area of study the former Harvard psychology professor, once known as Dr. Richard Alpert, devoted the rest of his life to exploring. Eventually, the living room and photographs dissolved, and viewers found themselves floating through the psychedelic cosmos, loaded with fractals, asteroids with mushrooms growing on them, Hindu deities, and other psychedelia elements.

That which was ‘I’ was beyond life and death,” said the famous author in the comforting voiceover explaining his psychedelic experience. “It was wise rather than just knowledgeable; it was a voice inside that spoke Truth. Now I need only look within to that place where ‘I’ knew.”

JOURNEY was a short and sweet ode to Ram Dass, who died at the age of 88 in December of 2019. And the experience probably would have been a lot sweeter under the influence of psychedelics, which are a part of TRIPP’s game plan, but not the entirety.

Reeves tells me after the screening that the company’s mission is to “stimulate not simulate” through the wellness app’s offerings, including guided meditations and interactive virtual environments, available on all Oculus and PlayStation headsets, as well as mobile devices, for just $20 a year.

Once TRIPP readies the JOURNEY experience for inclusion in their service offering, members will be able to relive Ram Dass’ first trip, or in a future version, potentially even create their own personalized JOURNEY. Chief Business Officer Mani Srinivasan says that the film I watched will eventually become customizable for premium subscribers that want to swap in their own photographs and narration to create a one-of-a-kind, digital ego dissolution trip.

A number of clinicians were organically using TRIPP to immerse patients in alternative realities and to support patients’ emotional and mental well-being before, during, and after ketamine therapy sessions. Subsequently, TRIPP acquired PsyAssist to empower psychotherapists and patients to safely and effectively use TRIPP’s XR technology (XR being the umbrella term for both virtual and augmented reality) for mental health and psychedelic-assisted therapy. Over time, in addition to supporting ketamine therapy with TRIPP PsyAssist, Srinivasan tells me he expects the same for psilocybin and MDMA-assisted therapy, once lawmakers ease restrictions for these substances to be clinically administered in controlled settings.

“Altered states of consciousness are often disorienting, overwhelming, and challenging to navigate and integrate,” Reeves said when announcing the acquisition last August. “TRIPP is essentially aiding trained experts when patients are not able to properly contextualize and absorb the psychedelic experience so they can get the most out of their treatment.”

TRIPP Wants You to 'Be Here Now,' With or Without Ram Dass

Reeves was an early investor in Oculus, and is the former COO of Machinima, an online video network focused on gamer culture, so virtual experiences have been on her mind for a long time. She tells me at the Ram Dass event that it was her late husband’s death that really inspired her to merge VR and gaming to create the mental and spiritual wellness platform.

Although I can definitely understand how XR technology can serve as a groovy psychedelic trip companion, leading the mind through a visual wonderland with a stimulating and calming soundtrack, Srinivasan emphasizes TRIPP may be best utilized before and after such an experience. The app can be used to help people prepare to get the most out of a life-changing psychedelic trip, and perhaps most valuable, help them stay connected to the experience through continued TRIPP meditations.

During our conversation, I tell Reeves that, for me, the real value of psychedelics is simply learning to exist in the moment for a few hours, without the usual flood of worldly thoughts and concerns distracting the mind. After all, getting high really means letting go of whatever burdens are weighing us down. Reeves agrees and tells me that’s what TRIPP is ultimately all about: with or without psychedelic drugs, she wants users to learn the subtle art of being.

The topic reminds Reeves of her late husband, a Tibetan Buddhist practitioner, who she fondly remembers spending an entire night sitting outside under the stars during a vacation they took shortly before he passed away. “I think he knew his time was coming,” she says.

Regardless of what he may have known, I think it sounds like the embodiment of Ram Dass’ advice to be here now, and Reeves hopes TRIPP can lead more people to profound experiences like that.

Similar Posts

  • The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]

    Hello psychedelic investors! Today’s episode will be a little different. We will discuss the recent media coverage of psychedelic stocks and its role in psychedelic inspired companies’ future.
    It appears that the mainstream media understands the potential for psychedelic stocks to disrupt the pharmaceutical Industry. Now understanding what this means, and its implications is extremely important for retail investors like you and me.
    We’ll also zoom into one piece of media about MindMed (MMED/MMEDF) and Compass Pathways (CMPS), and explore how it hits the nail on the head.
    We are going to do this because one, it’s a good article that I wanted to share with you
    And two, it exemplifies my point that the mainstream understands the potential here, and might actually be on the right side of history.

    P.S. I mention in the video that the article I’m discussing is by Yahoo Finance. It turns out the article is from OTC stock review.
    For those interested in reading the entire article: https://ca.movies.yahoo.com/264-million-reasons-psychedelic-stocks-133000885.html

    Time Stamps
    0:00​ – Intro
    3:10 – Media Coverage on Tesla & Psychedelic Stocks
    6:36 – Benefits of the media covering Psychedelic Companies like (MMEDF & CMPS)
    8:05 – Influence on stock valuations and stealth investors
    10:57 – 264 Million Reasons Why Psychedelic Stocks Have More Room To Grow

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor

    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​ ​ #MindmedStock​​ #PsychedelicStocks

  • This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI, FTPRF, ATAI & CYBN]

    In today’s episode of “This Week in Psychedelic Stocks”, we’ll see some News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Numinus Wellness (NUMI), Cybin (CYBN) & Fieldtrip Health (FTPRF).

    I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the EFSE so that mindmed news is not in this episode.

    We will cover the latest developments in the field writ large.
    This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.

    Timestamps:
    0:00 – Intro
    0:43 – Australian federal government funds psychedelic research to treat mental illnesses
    2:19 – Rhode Island wants to decriminalize all drugs
    3:54 – New York Bill to decriminalize psilocybin mushrooms
    6:34 – MindMed stock updates ( mmed, mmedf, mmq )
    8:17 – Compass Pathways stock news (cmps)
    8:49 – Atai Life Sciences news
    12:37 – Fieldtrip Health stock news ( ftprf, ftrp)
    15:04 – Numinus Wellness stock news ( NUMI, LKYSF)
    16:16 – Cybin stock news ( cybn, clxpf)
    18:18 General psychedelics discussion

    So this is it for This Week in Psychedelic Stocks fellow psychedelic investors!

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​ ​#MindmedStock​​ #PsychedelicStocks

  • Psychedelic Capital Conference – How to Watch FREE [ I Just Made the BIG LEAGUES]

    https://microdose.buzz/JAMESH
    Hey guys! as mentioned in our previous episode, I will be participating in the Psychedelic Capital Conference as a panel member! This is a monthly conference run by Microdose.buzz and it’s one of the most prestigious events where experts in the fields of investing and psychedelics, as well as industry insiders and leading companies all come together to discuss the topic of investing in psychedelic medicines.

    The event will take place on Monday May 31st, from 1:30PM to 5:10pmPM EST but you can just tune into my segment, which will be a 30 minute panel discussion, which will start at 2:20 PM.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @thepsychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    Video editing: @themyaholy
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #PsychedelicStocks #PsychedelicConference

    https://microdose.buzz/